Skip to main content
AEON logo

AEON Biopharma, Inc.

AEONNYSEAMERICANHealthcareBiotechnology

$0.18Today:- (-)1Y −80.75%

As of Nov 10, 2026 close

Market cap
$9.06M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.13$1.45
Volume (live)
-
Avg. volume (3M)
5.14M

AEON Biopharma (AEON) Stock Price & Financial Analysis

AEON Biopharma Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$0.18 - $0.18
52-Week High$1.45
52-Week Low$0.13
Open$0.18
Volume (last close)230.69K
Average Volume (3M)5.14M
Technical Indicators
50-Day MA$0.25
200-Day MA$0.64
1-Year Change−80.75%
Size & Valuation
Market Cap9.06M
Shares Outstanding50.53M
Price to Book (P/B)-0.59
EV/EBITDA-0.40
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%

Source: Market prices and company fundamentals. Data as of Nov 10, 2026. Data sources and methodology

Compare AEON with other stocks

AEON Biopharma at a Glance

As of the Nov 10, 2026 close, AEON Biopharma (AEON) has a market capitalization of $9.06M.

As of its latest reported balance sheet, it holds $3.43M in cash and securities against $2.02M of debt, a net cash position of $1.41M.

AEON Biopharma does not currently pay a dividend.

The share price is down 80.8% over the past year. At $0.18 (the Nov 10, 2026 close) it sits near the bottom of its 52-week range of $0.13 to $1.45, below its 200-day moving average of $0.64.

Frequently Asked Questions About AEON Biopharma

What is the current stock price for AEON?

As of the Nov 10, 2026 close, AEON stock trades at $0.18. The 52-week range is $0.13–$1.45, with a day range of $0.18–$0.18.

What is the P/E ratio for AEON?

AEON Biopharma has no trailing P/E ratio because it reported a net loss over the last twelve months.

Does AEON pay dividends?

AEON Biopharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What is the market cap of AEON?

As of the Nov 10, 2026 close, AEON Biopharma's market capitalization is $9.1M, classifying it as a micro-cap company. AEON Biopharma operates in the Healthcare sector within the Biotechnology industry.